Piperidinyl cyclopentyl aryl benzylamide modulators of chemokine receptor activity

Details for Australian Patent Application No. 2003284188 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors Paternak, Alexander; Zhou, Changyou; Yang, Lihu

Agent Spruson & Ferguson

Pub. Number AU-B-2003284188

PCT Number PCT/US2003/0340

PCT Pub. Number WO2004/041163

Priority 60/422,381 30.10.02 US

Filing date 24 October 2003

Wipo publication date 7 June 2004

Acceptance publication date 25 February 2010

International Classifications

C07D 211/14 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C07D 211/18 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 211/22 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 221/20 (2006.01) Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups

C07D 277/46 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 401/08 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 413/08 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/08 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 491/08 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

Event Publications

25 March 2004 Complete Application Filed

  Priority application(s): 60/422,381 30.10.02 US

1 July 2004 Application Open to Public Inspection

  Published as AU-B-2003284188

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

25 February 2010 Application Accepted

  Published as AU-B-2003284188

24 June 2010 Standard Patent Sealed

26 May 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003284189-SOY ISOFLAVONE CONCENTRATE PROCESS AND PRODUCT

2003284187-Inflammatory bowel disease and irritable bowel syndrome IBD-first chek diagnostic panel